3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Xeroderma Pigmentosum
1
Uterine Cervical Dysplasia
1
Trichothiodystrophy Syndromes
1
Squamous Intraepithelial Lesions
1
Sexuality
1
Oligodendroglioma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hematopoietic and Lymphatic System Neoplasm
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Endometrial Neoplasms
1
DNA Repair-Deficiency Disorders
1
Cockayne Syndrome
1
Carcinoma, Endometrioid
1
Breast Cancer Survivors
1
Bone Neoplasms
1
Atypical Squamous Cells of the Cervix
1
Astrocytoma
1
Interventions
Magnetic Resonance Spectroscopy
6
Biopsy
6
X-Rays
5
Specimen Handling
5
Phantoms, Imaging
5
Nuclear Medicine Department, Hospital
4
Cisplatin
3
Carboplatin
3
tazemetostat
2
selpercatinib
2
larotrectinib
2
erdafitinib
2
entrectinib
2
ensartinib
2
cabozantinib
2
Topotecan
2
Temozolomide
2
Surveys and Questionnaires
2
Radiation
2
LY3023414
2
Gemcitabine
2
Etoposide
2
Cyclophosphamide
2
ulixertinib
1
tipifarnib
1
pegfilgrastim
1
palbociclib
1
olaparib
1
niraparib
1
mirdametinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Central Nervous System Neoplasms
×
Restraint, Physical
×
90 days
×
Clear all
No trials found.